MY SIZE INC (MYSZ) Fundamental Analysis & Valuation

NASDAQ:MYSZ • US62844N4060

Current stock price

0.635 USD
0 (-0.36%)
Last:

This MYSZ fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

0

1. MYSZ Profitability Analysis

1.1 Basic Checks

  • In the past year MYSZ has reported negative net income.
  • MYSZ had a negative operating cash flow in the past year.
  • In the past 5 years MYSZ always reported negative net income.
  • MYSZ had a negative operating cash flow in each of the past 5 years.
MYSZ Yearly Net Income VS EBIT VS OCF VS FCFMYSZ Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 -2M -4M -6M -8M -10M

1.2 Ratios

  • With a Return On Assets value of -30.59%, MYSZ is not doing good in the industry: 77.57% of the companies in the same industry are doing better.
  • MYSZ has a worse Return On Equity (-48.86%) than 69.85% of its industry peers.
Industry RankSector Rank
ROA -30.59%
ROE -48.86%
ROIC N/A
ROA(3y)-65.37%
ROA(5y)-90.51%
ROE(3y)-125.25%
ROE(5y)-153.85%
ROIC(3y)N/A
ROIC(5y)N/A
MYSZ Yearly ROA, ROE, ROICMYSZ Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200 -200 400 -400 600

1.3 Margins

  • MYSZ has a Gross Margin of 38.67%. This is in the lower half of the industry: MYSZ underperforms 77.94% of its industry peers.
  • MYSZ's Gross Margin has declined in the last couple of years.
  • The Profit Margin and Operating Margin are not available for MYSZ so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 38.67%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-26.17%
GM growth 5Y-9.6%
MYSZ Yearly Profit, Operating, Gross MarginsMYSZ Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -2K -4K -6K -8K

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

3

2. MYSZ Health Analysis

2.1 Basic Checks

  • MYSZ does not have a ROIC to compare to the WACC, probably because it is not profitable.
  • The number of shares outstanding for MYSZ has been increased compared to 1 year ago.
  • Compared to 5 years ago, MYSZ has more shares outstanding
  • Compared to 1 year ago, MYSZ has an improved debt to assets ratio.
MYSZ Yearly Shares OutstandingMYSZ Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 500K 1M 1.5M 2M
MYSZ Yearly Total Debt VS Total AssetsMYSZ Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2M 4M 6M 8M 10M

2.2 Solvency

  • Based on the Altman-Z score of -7.45, we must say that MYSZ is in the distress zone and has some risk of bankruptcy.
  • With a Altman-Z score value of -7.45, MYSZ is not doing good in the industry: 87.87% of the companies in the same industry are doing better.
  • A Debt/Equity ratio of 0.13 indicates that MYSZ is not too dependend on debt financing.
  • With a Debt to Equity ratio value of 0.13, MYSZ perfoms like the industry average, outperforming 50.37% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.13
Debt/FCF N/A
Altman-Z -7.45
ROIC/WACCN/A
WACC9.16%
MYSZ Yearly LT Debt VS Equity VS FCFMYSZ Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5M -5M 10M

2.3 Liquidity

  • MYSZ has a Current Ratio of 2.73. This indicates that MYSZ is financially healthy and has no problem in meeting its short term obligations.
  • MYSZ's Current ratio of 2.73 is fine compared to the rest of the industry. MYSZ outperforms 71.69% of its industry peers.
  • MYSZ has a Quick Ratio of 1.72. This is a normal value and indicates that MYSZ is financially healthy and should not expect problems in meeting its short term obligations.
  • MYSZ's Quick ratio of 1.72 is in line compared to the rest of the industry. MYSZ outperforms 51.47% of its industry peers.
Industry RankSector Rank
Current Ratio 2.73
Quick Ratio 1.72
MYSZ Yearly Current Assets VS Current LiabilitesMYSZ Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2M 4M 6M 8M 10M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

6

3. MYSZ Growth Analysis

3.1 Past

  • The Earnings Per Share has grown by an impressive 66.53% over the past year.
  • The Revenue has grown by 56.90% in the past year. This is a very strong growth!
  • MYSZ shows a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 266.60% yearly.
EPS 1Y (TTM)66.53%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-383.33%
Revenue 1Y (TTM)56.9%
Revenue growth 3Y266.6%
Revenue growth 5YN/A
Sales Q2Q%127.15%

3.2 Future

  • The Earnings Per Share is expected to grow by 23.50% on average over the next years. This is a very strong growth
  • The Revenue is expected to grow by 19.07% on average over the next years. This is quite good.
EPS Next Y82.6%
EPS Next 2Y37.5%
EPS Next 3Y23.5%
EPS Next 5YN/A
Revenue Next Year20.8%
Revenue Next 2Y11.41%
Revenue Next 3Y19.07%
Revenue Next 5YN/A

3.3 Evolution

  • The estimated forward Revenue growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
MYSZ Yearly Revenue VS EstimatesMYSZ Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2019 2020 2021 2022 2023 2024 2025 2026 2M 4M 6M 8M 10M
MYSZ Yearly EPS VS EstimatesMYSZ Yearly EPS VS EstimatesYearly EPS VS Estimates 2020 2021 2023 2024 2025 2026 -100 -200 -300

More info and screens

Find the best growth stocksShow best growing peers

1

4. MYSZ Valuation Analysis

4.1 Price/Earnings Ratio

  • The Price/Earnings Ratio is negative for MYSZ. In the last year negative earnings were reported.
  • Also next year MYSZ is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
MYSZ Price Earnings VS Forward Price EarningsMYSZ Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 20 30

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
MYSZ Per share dataMYSZ EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 -5 -10 -15 -20

4.3 Compensation for Growth

  • MYSZ's earnings are expected to grow with 23.50% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y37.5%
EPS Next 3Y23.5%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. MYSZ Dividend Analysis

5.1 Amount

  • MYSZ does not give a dividend.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

MYSZ Fundamentals: All Metrics, Ratios and Statistics

MY SIZE INC

NASDAQ:MYSZ (4/29/2026, 8:00:01 PM)

0.635

0 (-0.36%)

Chartmill FA Rating
GICS IndustryGroupSoftware & Services
GICS IndustrySoftware
Industry StrengthN/A
Industry GrowthN/A
Earnings (Last)04-15
Earnings (Next)N/A
Inst Owners3.45%
Inst Owner Change3.28%
Ins Owners14.96%
Ins Owner Change13.7%
Market Cap2.44M
Revenue(TTM)7.00M
Net Income(TTM)-3.56M
Analysts82.86
Price Target3.06 (381.89%)
Short Float %2.43%
Short Ratio1.64
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)0%
EPS NQ rev (3m)0%
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.33
P/FCF N/A
P/OCF N/A
P/B 0.34
P/tB 0.51
EV/EBITDA N/A
EPS(TTM)-23.68
EYN/A
EPS(NY)-2.59
Fwd EYN/A
FCF(TTM)-0.88
FCFYN/A
OCF(TTM)-0.88
OCFYN/A
SpS1.95
BVpS1.9
TBVpS1.26
PEG (NY)N/A
PEG (5Y)N/A
Graham Number0 (-100%)
Profitability
Industry RankSector Rank
ROA -30.59%
ROE -48.86%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 38.67%
FCFM N/A
ROA(3y)-65.37%
ROA(5y)-90.51%
ROE(3y)-125.25%
ROE(5y)-153.85%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-26.17%
GM growth 5Y-9.6%
F-Score3
Asset Turnover0.64
Health
Industry RankSector Rank
Debt/Equity 0.13
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 2.73
Quick Ratio 1.72
Altman-Z -7.45
F-Score3
WACC9.16%
ROIC/WACCN/A
Cap/Depr(3y)6.12%
Cap/Depr(5y)22.62%
Cap/Sales(3y)0.26%
Cap/Sales(5y)5.92%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)66.53%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-383.33%
EPS Next Y82.6%
EPS Next 2Y37.5%
EPS Next 3Y23.5%
EPS Next 5YN/A
Revenue 1Y (TTM)56.9%
Revenue growth 3Y266.6%
Revenue growth 5YN/A
Sales Q2Q%127.15%
Revenue Next Year20.8%
Revenue Next 2Y11.41%
Revenue Next 3Y19.07%
Revenue Next 5YN/A
EBIT growth 1Y0.06%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y46.36%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y46.77%
OCF growth 3YN/A
OCF growth 5YN/A

MY SIZE INC / MYSZ Fundamental Analysis FAQ

What is the fundamental rating for MYSZ stock?

ChartMill assigns a fundamental rating of 2 / 10 to MYSZ.


What is the valuation status for MYSZ stock?

ChartMill assigns a valuation rating of 1 / 10 to MY SIZE INC (MYSZ). This can be considered as Overvalued.


What is the profitability of MYSZ stock?

MY SIZE INC (MYSZ) has a profitability rating of 0 / 10.


What is the expected EPS growth for MY SIZE INC (MYSZ) stock?

The Earnings per Share (EPS) of MY SIZE INC (MYSZ) is expected to grow by 82.6% in the next year.